Tharimmune Stock (NASDAQ: THAR) stock price, news, charts, stock research, profile.
You can purchase shares of Tharimmune (NASDAQ:THAR) through any online brokerage.
Other companies in Tharimmune’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX), Palisade Bio (NASDAQ:PALI) and NuCana (NASDAQ:NCNA).
Tharimmune has a consensus price target of $17.00.
The stock price for Tharimmune (NASDAQ: THAR) is $2.0001 last updated January 10, 2025 at 4:05 PM EST.
There are no upcoming dividends for Tharimmune.
Tharimmune’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Tharimmune.
Tharimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.